+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Intelligence (AI) in Drug Discovery Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

  • ID: 5475169
  • Report
  • October 2021
  • Region: Global
  • 100 Pages
  • Infinium Global Research

FEATURED COMPANIES

  • Alphabet Inc.
  • Atomwise Inc.
  • BenevolentAI Limited
  • Cyclica Inc.
  • Deep Genomics
  • Exscientia plc
The report on the global artificial intelligence (AI) in drug discovery market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global artificial intelligence (AI) in drug discovery market to grow with a CAGR of 30.2% over the forecast period from 2021-2027. The study on artificial intelligence (AI) in drug discovery market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.



The report on artificial intelligence (AI) in drug discovery market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global artificial intelligence (AI) in drug discovery market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global artificial intelligence (AI) in drug discovery market over the period of 2019 to 2027. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings


1) Drivers

  • Increasing use of artificial intelligence to efficiently study the drug activity
  • Reduced costs of drug discovery

2) Restraints

  • Low quality and inconsistent available data

3) Opportunities

  • Generation of huge amount of data

Research Methodology


A) Primary Research


Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.


B) Secondary Research


Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered


The global artificial intelligence (AI) in drug discovery market is segmented on the basis of offering, technology, application, indication, and end user.

The Global Artificial Intelligence (AI) in Drug Discovery Market by Offering

  • Software
  • Services

The Global Artificial Intelligence (AI) in Drug Discovery Market by Technology

  • Machine Learning
  • Natural Language Processing (NLP)
  • Computer Vision
  • Others

The Global Artificial Intelligence (AI) in Drug Discovery Market by Application

  • Target Identification
  • Molecule Screening
  • Drug Design and Drug Optimization
  • Preclinical and Clinical Testing
  • Others

The Global Artificial Intelligence (AI) in Drug Discovery Market by Indication

  • Oncology
  • Neurodegenerative Diseases
  • Infectious Disease
  • Others

The Global Artificial Intelligence (AI) in Drug Discovery Market by End User

  • Pharmaceutical & BIoTechnology Companies
  • Contract Research Organizations
  • Academic & Government Research Institutes

Company Profiles


The companies covered in the report include
  • GNS Healthcare
  • BenevolentAI Limited
  • Atomwise Inc.
  • Cyclica Inc.
  • Deep Genomics
  • Exscientia plc
  • IBM Corporation
  • Alphabet Inc.
  • NVIDIA Corporation
  • Microsoft Corporation

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the artificial intelligence (AI) in drug discovery market.
2. Complete coverage of all the segments in the artificial intelligence (AI) in drug discovery market to analyze the trends, developments in the global market and forecast of market size up to 2027.
3. Comprehensive analysis of the companies operating in the global artificial intelligence (AI) in drug discovery market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Frequently Asked Questions about the Artificial Intelligence (AI) in Drug Discovery Market

What is the estimated value of the Artificial Intelligence (AI) in Drug Discovery Market?

The Artificial Intelligence (AI) in Drug Discovery Market was estimated to be valued at $855.5 Million in 2021.

What is the growth rate of the Artificial Intelligence (AI) in Drug Discovery Market?

The growth rate of the Artificial Intelligence (AI) in Drug Discovery Market is 30.2%, with an estimated value of $4167.0 Million by 2027.

What is the forecasted size of the Artificial Intelligence (AI) in Drug Discovery Market?

The Artificial Intelligence (AI) in Drug Discovery Market is estimated to be worth $4167.0 Million by 2027.

Who are the key companies in the Artificial Intelligence (AI) in Drug Discovery Market?

Key companies in the Artificial Intelligence (AI) in Drug Discovery Market include GNS Healthcare, BenevolentAI Limited, Atomwise Inc., Cyclica Inc., Deep Genomics, Exscientia plc, IBM Corporation, Alphabet Inc. and Microsoft Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alphabet Inc.
  • Atomwise Inc.
  • BenevolentAI Limited
  • Cyclica Inc.
  • Deep Genomics
  • Exscientia plc

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Artificial Intelligence (AI) in Drug Discovery Market Highlights
2.2. Artificial Intelligence (AI) in Drug Discovery Market Projection
2.3. Artificial Intelligence (AI) in Drug Discovery Market Regional Highlights
3. Global Artificial Intelligence (AI) in Drug Discovery Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Artificial Intelligence (AI) in Drug Discovery Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Offering
3.5.2. Growth Matrix Analysis by Technology
3.5.3. Growth Matrix Analysis by Application
3.5.4. Growth Matrix Analysis by Indication
3.5.5. Growth Matrix Analysis by End User
3.5.6. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Artificial Intelligence (AI) in Drug Discovery Market
4. Artificial Intelligence (AI) in Drug Discovery Market Macro Indicator Analysis
5. Global Artificial Intelligence (AI) in Drug Discovery Market by Offering
5.1. Software
5.2. Services
6. Global Artificial Intelligence (AI) in Drug Discovery Market by Technology
6.1. Machine Learning
6.2. Natural Language Processing (NLP)
6.3. Computer Vision
6.4. Others
7. Global Artificial Intelligence (AI) in Drug Discovery Market by Application
7.1. Target Identification
7.2. Molecule Screening
7.3. Drug Design and Drug Optimization
7.4. Preclinical and Clinical Testing
7.5. Others
8. Global Artificial Intelligence (AI) in Drug Discovery Market by Indication
8.1. Oncology
8.2. Neurodegenerative Diseases
8.3. Infectious Disease
8.4. Others
9. Global Artificial Intelligence (AI) in Drug Discovery Market by End User
9.1. Pharmaceutical & BIoTechnology Companies
9.2. Contract Research Organizations
9.3. Academic & Government Research Institutes
10. Global Artificial Intelligence (AI) in Drug Discovery Market by Region 2021-2027
10.1. North America
10.1.1. North America Artificial Intelligence (AI) in Drug Discovery Market by Offering
10.1.2. North America Artificial Intelligence (AI) in Drug Discovery Market by Technology
10.1.3. North America Artificial Intelligence (AI) in Drug Discovery Market by Application
10.1.4. North America Artificial Intelligence (AI) in Drug Discovery Market by Indication
10.1.5. North America Artificial Intelligence (AI) in Drug Discovery Market by End User
10.1.6. North America Artificial Intelligence (AI) in Drug Discovery Market by Country
10.2. Europe
10.2.1. Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering
10.2.2. Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology
10.2.3. Europe Artificial Intelligence (AI) in Drug Discovery Market by Application
10.2.4. Europe Artificial Intelligence (AI) in Drug Discovery Market by Indication
10.2.5. Europe Artificial Intelligence (AI) in Drug Discovery Market by End User
10.2.6. Europe Artificial Intelligence (AI) in Drug Discovery Market by Country
10.3. Asia-Pacific
10.3.1. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering
10.3.2. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology
10.3.3. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Application
10.3.4. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Indication
10.3.5. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by End User
10.3.6. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Country
10.4. RoW
10.4.1. RoW Artificial Intelligence (AI) in Drug Discovery Market by Offering
10.4.2. RoW Artificial Intelligence (AI) in Drug Discovery Market by Technology
10.4.3. RoW Artificial Intelligence (AI) in Drug Discovery Market by Application
10.4.4. RoW Artificial Intelligence (AI) in Drug Discovery Market by Indication
10.4.5. RoW Artificial Intelligence (AI) in Drug Discovery Market by End User
10.4.6. RoW Artificial Intelligence (AI) in Drug Discovery Market by Sub-region
11. Company Profiles and Competitive Landscape
11.1. Competitive Landscape in the Global Artificial Intelligence (AI) in Drug Discovery Market
11.2. Companies Profiled
11.2.1. GNS Healthcare
11.2.2. BenevolentAI Limited
11.2.3. Atomwise Inc.
11.2.4. Cyclica Inc.
11.2.5. Deep Genomics
11.2.6. Exscientia plc
11.2.7. IBM Corporation
11.2.8. Alphabet Inc.
11.2.9. NVIDIA Corporation
11.2.10. Microsoft Corporation
Note: Product cover images may vary from those shown
  • GNS Healthcare
  • BenevolentAI Limited
  • Atomwise Inc.
  • Cyclica Inc.
  • Deep Genomics
  • Exscientia plc
  • IBM Corporation
  • Alphabet Inc.
  • NVIDIA Corporation
  • Microsoft Corporation
Note: Product cover images may vary from those shown